• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 10/01/14

    • 30-Day SEC Yield1

      -0.14%
    • Total Net Assets

      $531.6M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 10/01/14

    • % of Net Assets
    • Stocks

      99.86
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.14
  • Download All HoldingsAll Holdings (%)as of 10/01/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    794,445
    83,885,44815.78
    Amgen Inc
    AMGN US
    440,299
    61,122,30711.50
    Celgene Corp
    CELG US
    549,935
    51,380,4279.67
    Biogen Idec Inc
    BIIB US
    138,704
    44,870,7448.44
    Vertex Pharmaceuticals Inc
    VRTX US
    258,671
    27,742,4655.22
    Alexion Pharmaceuticals Inc
    ALXN US
    164,379
    27,484,1695.17
    Regeneron Pharmaceuticals Inc
    REGN US
    69,165
    24,595,7664.63
    Illumina Inc
    ILMN US
    137,568
    21,832,0424.11
    Biomarin Pharmaceutical Inc
    BMRN US
    272,162
    19,162,9263.61
    Medivation Inc
    MDVN US
    188,499
    18,915,8753.56
    Pharmacyclics Inc
    PCYC US
    157,992
    18,295,4743.44
    Qiagen Nv
    QGEN US
    743,794
    16,824,6203.17
    Incyte Corp Ltd
    INCY US
    341,514
    16,361,9363.08
    United Therapeutics Corp
    UTHR US
    107,626
    14,038,7352.64
    Puma Biotechnology Inc
    PBYI US
    50,360
    11,849,7082.23
    Cubist Pharmaceuticals Inc
    CBST US
    164,352
    10,641,7922.00
    Covance Inc
    CVD US
    118,663
    9,146,5441.72
    Alkermes Plc
    ALKS US
    207,521
    8,605,8961.62
    Intercept Pharmaceuticals Inc
    ICPT US
    36,988
    8,499,4731.60
    Isis Pharmaceuticals Inc
    ISIS US
    217,806
    8,246,1351.55
    Charles River Laboratories Internationa
    CRL US
    119,563
    7,068,5651.33
    Nps Pharmaceuticals Inc
    NPSP US
    231,256
    5,795,2751.09
    Cepheid Inc
    CPHD US
    129,883
    5,652,5081.06
    Myriad Genetics Inc
    MYGN US
    124,309
    4,761,0350.90
    Seattle Genetics Inc
    SGEN US
    109,796
    4,053,6680.76
    Other/Cash
    725,4770.14
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.